Versor Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,692
| Closed | -$428K | – | 839 |
|
|
2023
Q4 | $428K | Buy |
12,692
+4,397
| +53% | +$148K | 0.09% | 386 |
|
|
2023
Q3 | $254K | Sell |
8,295
-4,474
| -35% | -$137K | 0.05% | 528 |
|
|
2023
Q2 | $512K | Sell |
12,769
-1,075
| -8% | -$43.1K | 0.09% | 252 |
|
|
2023
Q1 | $565K | Sell |
13,844
-2,203
| -14% | -$89.9K | 0.07% | 283 |
|
|
2022
Q4 | $620K | Buy |
+16,047
| New | +$620K | 0.05% | 277 |
|
|
2022
Q3 | – | Sell |
-4,200
| Closed | -$245K | – | 909 |
|
|
2022
Q2 | $245K | Buy |
+4,200
| New | +$245K | 0.01% | 692 |
|
|
2020
Q2 | – | Sell |
-14,732
| Closed | -$494K | – | 273 |
|
|
2020
Q1 | $494K | Buy |
+14,732
| New | +$494K | 0.03% | 114 |
|